ALS TDI Research Center

Clinical Trials

No effective ALS treatments are currently available in the marketplace. But today's clinical trials may lead to tomorrow's cure.

Recent Trial Launches:

Research Feed

  • TDI-053 7/3/2014 - completed survival/efficacy studies using this immune system modulating protein and began analysis of data
  • TDI-106 7/3/2014 - began new PK/PD studies using a modified version of this immunomodulating protein biologic
  • TDI-154 7/3/2014 - This small molecule targeting autophagy/proteasome entered was tested and found not to be efficacious. Closed project.
  • TDI-156 7/3/2014 - in vivo survival/efficacy studies began on this small molecule targeting the unfolded protein response mechanism.
  • TDI-186 7/3/2014 - Advanced this small molecule targeting UPR into in vitro validation

Stats from the Lab

1000

transcriptome analyzed each year

20

complete PK studies each year

100

TDP43 mice used each month